Within Anti-Glycan Antibody Research Services, we offers a glycan and glycopeptide immunogen design service built for projects in which antigen presentation determines whether an antibody campaign starts with a meaningful epitope or with an over-simplified conjugate. When difficult antigens are weakly immunogenic, highly glycoform dependent, or strongly influenced by carrier protein and linker context, front-end immunogen design becomes critical to later hybridoma generation, phage display screening, and specificity-focused assay development.